{"id":5592,"date":"2025-03-08T20:34:53","date_gmt":"2025-03-08T13:34:53","guid":{"rendered":"https:\/\/regular-investor.com\/?p=5592"},"modified":"2025-03-08T20:34:57","modified_gmt":"2025-03-08T13:34:57","slug":"kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah","status":"publish","type":"post","link":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/","title":{"rendered":"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah"},"content":{"rendered":"\n<p><strong>Kinerja PT Kalbe Farma Tbk Tahun 2024: Pendapatan dan Laba Bersih<\/strong><\/p>\n\n\n\n<p>PT Kalbe Farma Tbk mencatatkan kinerja yang menggembirakan sepanjang tahun 2024. Berdasarkan laporan keuangan dan analisis pasar, perusahaan ini berhasil mencatatkan total laba bersih sebesar Rp3,24 triliun, meningkat 17,1% secara tahunan (YoY). Peningkatan ini didukung oleh pertumbuhan pendapatan sebesar 7% YoY, yang mencapai Rp16,3 triliun pada semester pertama 2024.<\/p>\n\n\n\n<p>Faktor utama yang mendorong pertumbuhan laba bersih adalah peningkatan margin laba kotor yang mencapai 41,3%, lebih tinggi dibandingkan tahun sebelumnya. Segmen distribusi dan logistik menjadi salah satu pendorong utama, dengan pertumbuhan 17,1% YoY, berkat ekspansi bisnis melalui Enseval dan penambahan prinsipal baru.<\/p>\n\n\n\n<p><strong>Prospek Bisnis Kalbe Farma ke Depan<\/strong><\/p>\n\n\n\n<p>Ke depan, prospek bisnis Kalbe Farma tetap positif meskipun menghadapi tantangan seperti fluktuasi nilai tukar rupiah dan persaingan yang ketat di pasar farmasi. Perusahaan telah mengambil langkah strategis untuk mengurangi risiko ini, seperti meningkatkan penggunaan mata uang Chinese Yuan dalam transaksi pembelian bahan baku dari China.<\/p>\n\n\n\n<p>Kalbe Farma juga berencana memperkuat segmen farmasi dengan mengembangkan obat biologi, terapi sel, dan vaksin. Selain itu, perusahaan akan fokus pada produk kesehatan preventif dan wellness, serta memperluas kategori produk nutrisi dengan harga lebih terjangkau.<\/p>\n\n\n\n<p>Dengan strategi ini, manajemen Kalbe Farma menargetkan pertumbuhan pendapatan dan laba bersih sebesar 8%-10% YoY pada tahun 2025. Langkah-langkah ini diharapkan dapat menjaga posisi Kalbe Farma sebagai salah satu pemimpin pasar di industri farmasi Indonesia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kinerja PT Kalbe Farma Tbk Tahun 2024: Pendapatan dan Laba Bersih PT Kalbe Farma Tbk mencatatkan kinerja yang menggembirakan sepanjang tahun 2024. Berdasarkan laporan keuangan dan analisis pasar, perusahaan ini berhasil mencatatkan total laba bersih sebesar Rp3,24 triliun, meningkat 17,1% secara tahunan (YoY). Peningkatan ini didukung oleh pertumbuhan pendapatan sebesar 7% YoY, yang mencapai Rp16,3 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":5593,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_links_to":"","_links_to_target":""},"categories":[288],"tags":[2697,2696],"class_list":["post-5592","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-klbf","tag-pt-kalbe-farma-tbk"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah - Regular-investor.com<\/title>\n<meta name=\"description\" content=\"Kinerja PT Kalbe Farma Tbk di tahun 2024 dengan peningkatan laba bersih 17,1%. Temukan strategi inovatif Kalbe Farma yang menjanjikan prospek bisnis gemilang di industri farmasi Indonesia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah - Regular-investor.com\" \/>\n<meta property=\"og:description\" content=\"Kinerja PT Kalbe Farma Tbk di tahun 2024 dengan peningkatan laba bersih 17,1%. Temukan strategi inovatif Kalbe Farma yang menjanjikan prospek bisnis gemilang di industri farmasi Indonesia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/\" \/>\n<meta property=\"og:site_name\" content=\"Regular-investor.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/regularinvestorscom\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-08T13:34:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-08T13:34:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regular-investor.com\/wp-content\/uploads\/2025\/03\/Kalbe-KLBF.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"734\" \/>\n\t<meta property=\"og:image:height\" content=\"410\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Regular Investors\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@rinvestorcom\" \/>\n<meta name=\"twitter:site\" content=\"@rinvestorcom\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regular Investors\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/\"},\"author\":{\"name\":\"Regular Investors\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#\\\/schema\\\/person\\\/1576dc325e2683ab95d1eab23339f261\"},\"headline\":\"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah\",\"datePublished\":\"2025-03-08T13:34:53+00:00\",\"dateModified\":\"2025-03-08T13:34:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/\"},\"wordCount\":225,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regular-investor.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Kalbe-KLBF.jpg\",\"keywords\":[\"KLBF\",\"PT Kalbe Farma Tbk\"],\"articleSection\":[\"Market\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/\",\"url\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/\",\"name\":\"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah - Regular-investor.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regular-investor.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Kalbe-KLBF.jpg\",\"datePublished\":\"2025-03-08T13:34:53+00:00\",\"dateModified\":\"2025-03-08T13:34:57+00:00\",\"description\":\"Kinerja PT Kalbe Farma Tbk di tahun 2024 dengan peningkatan laba bersih 17,1%. Temukan strategi inovatif Kalbe Farma yang menjanjikan prospek bisnis gemilang di industri farmasi Indonesia.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regular-investor.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Kalbe-KLBF.jpg\",\"contentUrl\":\"https:\\\/\\\/regular-investor.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Kalbe-KLBF.jpg\",\"width\":734,\"height\":410},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/index.php\\\/2025\\\/03\\\/08\\\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/regular-investor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#website\",\"url\":\"https:\\\/\\\/regular-investor.com\\\/\",\"name\":\"Regular-investor.com\",\"description\":\"You Sleep and Makes Money\",\"publisher\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#organization\"},\"alternateName\":\"R-INVESTOR\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regular-investor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#organization\",\"name\":\"Regular-investor.com\",\"alternateName\":\"R-INVESTOR\",\"url\":\"https:\\\/\\\/regular-investor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regular-investor.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-Photoroom-20250309_055542.png\",\"contentUrl\":\"https:\\\/\\\/regular-investor.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-Photoroom-20250309_055542.png\",\"width\":512,\"height\":512,\"caption\":\"Regular-investor.com\"},\"image\":{\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/regularinvestorscom\",\"https:\\\/\\\/x.com\\\/rinvestorcom\",\"https:\\\/\\\/www.instagram.com\\\/regularinvestorcom\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regular-investor.com\\\/#\\\/schema\\\/person\\\/1576dc325e2683ab95d1eab23339f261\",\"name\":\"Regular Investors\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b9ba989c7841dd8f6c5b1e0b671094c02cfbc2ae624447be7ba492063d716933?s=96&d=wavatar&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b9ba989c7841dd8f6c5b1e0b671094c02cfbc2ae624447be7ba492063d716933?s=96&d=wavatar&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b9ba989c7841dd8f6c5b1e0b671094c02cfbc2ae624447be7ba492063d716933?s=96&d=wavatar&r=g\",\"caption\":\"Regular Investors\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah - Regular-investor.com","description":"Kinerja PT Kalbe Farma Tbk di tahun 2024 dengan peningkatan laba bersih 17,1%. Temukan strategi inovatif Kalbe Farma yang menjanjikan prospek bisnis gemilang di industri farmasi Indonesia.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/","og_locale":"en_US","og_type":"article","og_title":"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah - Regular-investor.com","og_description":"Kinerja PT Kalbe Farma Tbk di tahun 2024 dengan peningkatan laba bersih 17,1%. Temukan strategi inovatif Kalbe Farma yang menjanjikan prospek bisnis gemilang di industri farmasi Indonesia.","og_url":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/","og_site_name":"Regular-investor.com","article_publisher":"https:\/\/facebook.com\/regularinvestorscom","article_published_time":"2025-03-08T13:34:53+00:00","article_modified_time":"2025-03-08T13:34:57+00:00","og_image":[{"width":734,"height":410,"url":"https:\/\/regular-investor.com\/wp-content\/uploads\/2025\/03\/Kalbe-KLBF.jpg","type":"image\/jpeg"}],"author":"Regular Investors","twitter_card":"summary_large_image","twitter_creator":"@rinvestorcom","twitter_site":"@rinvestorcom","twitter_misc":{"Written by":"Regular Investors","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/#article","isPartOf":{"@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/"},"author":{"name":"Regular Investors","@id":"https:\/\/regular-investor.com\/#\/schema\/person\/1576dc325e2683ab95d1eab23339f261"},"headline":"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah","datePublished":"2025-03-08T13:34:53+00:00","dateModified":"2025-03-08T13:34:57+00:00","mainEntityOfPage":{"@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/"},"wordCount":225,"commentCount":0,"publisher":{"@id":"https:\/\/regular-investor.com\/#organization"},"image":{"@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/#primaryimage"},"thumbnailUrl":"https:\/\/regular-investor.com\/wp-content\/uploads\/2025\/03\/Kalbe-KLBF.jpg","keywords":["KLBF","PT Kalbe Farma Tbk"],"articleSection":["Market"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/","url":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/","name":"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah - Regular-investor.com","isPartOf":{"@id":"https:\/\/regular-investor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/#primaryimage"},"image":{"@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/#primaryimage"},"thumbnailUrl":"https:\/\/regular-investor.com\/wp-content\/uploads\/2025\/03\/Kalbe-KLBF.jpg","datePublished":"2025-03-08T13:34:53+00:00","dateModified":"2025-03-08T13:34:57+00:00","description":"Kinerja PT Kalbe Farma Tbk di tahun 2024 dengan peningkatan laba bersih 17,1%. Temukan strategi inovatif Kalbe Farma yang menjanjikan prospek bisnis gemilang di industri farmasi Indonesia.","breadcrumb":{"@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/#primaryimage","url":"https:\/\/regular-investor.com\/wp-content\/uploads\/2025\/03\/Kalbe-KLBF.jpg","contentUrl":"https:\/\/regular-investor.com\/wp-content\/uploads\/2025\/03\/Kalbe-KLBF.jpg","width":734,"height":410},{"@type":"BreadcrumbList","@id":"https:\/\/regular-investor.com\/index.php\/2025\/03\/08\/kinerja-cemerlang-kalbe-farma-2024-pendapatan-melonjak-prospek-bisnis-cerah\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/regular-investor.com\/"},{"@type":"ListItem","position":2,"name":"Kinerja Cemerlang Kalbe Farma 2024: Pendapatan Melonjak, Prospek Bisnis Cerah"}]},{"@type":"WebSite","@id":"https:\/\/regular-investor.com\/#website","url":"https:\/\/regular-investor.com\/","name":"Regular-investor.com","description":"You Sleep and Makes Money","publisher":{"@id":"https:\/\/regular-investor.com\/#organization"},"alternateName":"R-INVESTOR","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regular-investor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/regular-investor.com\/#organization","name":"Regular-investor.com","alternateName":"R-INVESTOR","url":"https:\/\/regular-investor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/regular-investor.com\/#\/schema\/logo\/image\/","url":"https:\/\/regular-investor.com\/wp-content\/uploads\/2025\/03\/cropped-Photoroom-20250309_055542.png","contentUrl":"https:\/\/regular-investor.com\/wp-content\/uploads\/2025\/03\/cropped-Photoroom-20250309_055542.png","width":512,"height":512,"caption":"Regular-investor.com"},"image":{"@id":"https:\/\/regular-investor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/regularinvestorscom","https:\/\/x.com\/rinvestorcom","https:\/\/www.instagram.com\/regularinvestorcom\/"]},{"@type":"Person","@id":"https:\/\/regular-investor.com\/#\/schema\/person\/1576dc325e2683ab95d1eab23339f261","name":"Regular Investors","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b9ba989c7841dd8f6c5b1e0b671094c02cfbc2ae624447be7ba492063d716933?s=96&d=wavatar&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b9ba989c7841dd8f6c5b1e0b671094c02cfbc2ae624447be7ba492063d716933?s=96&d=wavatar&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b9ba989c7841dd8f6c5b1e0b671094c02cfbc2ae624447be7ba492063d716933?s=96&d=wavatar&r=g","caption":"Regular Investors"}}]}},"jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/posts\/5592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/comments?post=5592"}],"version-history":[{"count":1,"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/posts\/5592\/revisions"}],"predecessor-version":[{"id":5594,"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/posts\/5592\/revisions\/5594"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/media\/5593"}],"wp:attachment":[{"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/media?parent=5592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/categories?post=5592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regular-investor.com\/index.php\/wp-json\/wp\/v2\/tags?post=5592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}